BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32568624)

  • 1. Emerging importance of molecular pathogenesis of vascular malformations in clinical practice and classifications.
    Pang C; Lim CS; Brookes J; Tsui J; Hamilton G
    Vasc Med; 2020 Aug; 25(4):364-377. PubMed ID: 32568624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular changes associated with vascular malformations.
    Fereydooni A; Dardik A; Nassiri N
    J Vasc Surg; 2019 Jul; 70(1):314-326.e1. PubMed ID: 30922748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Basis and Therapies for Vascular Anomalies.
    Queisser A; Seront E; Boon LM; Vikkula M
    Circ Res; 2021 Jun; 129(1):155-173. PubMed ID: 34166070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated TGF-β/BMP Signaling in Vascular Malformations.
    Cunha SI; Magnusson PU; Dejana E; Lampugnani MG
    Circ Res; 2017 Sep; 121(8):981-999. PubMed ID: 28963191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of vascular malformation and therapeutic implications.
    Zúñiga-Castillo M; Teng CL; Teng JMC
    Curr Opin Pediatr; 2019 Aug; 31(4):498-508. PubMed ID: 31246627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular and Lymphatic Malformations: Perspectives From Human and Vertebrate Studies.
    Janardhan HP; Saheera S; Jung R; Trivedi CM
    Circ Res; 2021 Jun; 129(1):131-135. PubMed ID: 34166069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of vascular birthmarks.
    Mahajan P; Bergstrom KL; Phung TL; Metry DW
    Clin Dermatol; 2022; 40(4):313-321. PubMed ID: 35181412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISSVA Classification of Vascular Anomalies and Molecular Biology.
    Kunimoto K; Yamamoto Y; Jinnin M
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Causes of Vascular Malformations and Common Signaling Pathways Involved in Their Formation.
    Rose AL; Cathey SS
    Dermatol Clin; 2022 Oct; 40(4):449-459. PubMed ID: 36243432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the endothelial pathogenic mechanism of TIE2-related venous malformation.
    Du Z; Zheng J; Zhang Z; Wang Y
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):740-748. PubMed ID: 28818232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD10 and CD34 as markers in vascular malformations with PIK3CA and TEK mutations.
    Moneghini L; Tosi D; Graziani D; Caretti A; Colletti G; Baraldini V; Cattaneo E; Spaccini L; Zocca A; Bulfamante GP
    Hum Pathol; 2020 May; 99():98-106. PubMed ID: 32272124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations.
    Ye C; Pan L; Huang Y; Ye R; Han A; Li S; Li X; Wang S
    J Vasc Surg; 2011 Dec; 54(6):1760-8. PubMed ID: 21962923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A xenograft model for venous malformation.
    Goines J; Li X; Cai Y; Mobberley-Schuman P; Metcalf M; Fishman SJ; Adams DM; Hammill AM; Boscolo E
    Angiogenesis; 2018 Nov; 21(4):725-735. PubMed ID: 29786783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How we approach the use of sirolimus and new agents: Medical therapy to treat vascular anomalies.
    Shimano KA; Eng W; Adams DM
    Pediatr Blood Cancer; 2022 Aug; 69 Suppl 3():e29603. PubMed ID: 35253343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classification of vascular tumors and malformations: basis for classification and clinical purpose].
    Moure C; Reynaert G; Lehmman P; Testelin S; Devauchelle B
    Rev Stomatol Chir Maxillofac; 2007 Jun; 108(3):201-9. PubMed ID: 17532354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations.
    di Blasio L; Puliafito A; Gagliardi PA; Comunanza V; Somale D; Chiaverina G; Bussolino F; Primo L
    Cell Death Dis; 2018 Jan; 9(2):45. PubMed ID: 29352118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-of-Function Mutations in ELMO2 Cause Intraosseous Vascular Malformation by Impeding RAC1 Signaling.
    Cetinkaya A; Xiong JR; Vargel İ; Kösemehmetoğlu K; Canter Hİ; Gerdan ÖF; Longo N; Alzahrani A; Camps MP; Taskiran EZ; Laupheimer S; Botto LD; Paramalingam E; Gormez Z; Uz E; Yuksel B; Ruacan Ş; Sağıroğlu MŞ; Takahashi T; Reversade B; Akarsu NA
    Am J Hum Genet; 2016 Aug; 99(2):299-317. PubMed ID: 27476657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perspectives on molecular diagnosis and targeted therapy for complex vascular malformations in pediatrics].
    Zhang B; He R; Song L; Ma L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Sep; 57(9):1481-1488. PubMed ID: 37743312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular tumours and malformations, classification, pathology and imaging].
    Wassef M; Vanwijck R; Clapuyt P; Boon L; Magalon G
    Ann Chir Plast Esthet; 2006; 51(4-5):263-81. PubMed ID: 17005309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.